Humacyte, Inc.
NASDAQ:HUMABiotechnology
Healthcare
$0.50 -3.35%
-$0.03 today
- Market cap
- $139.18M
- Beta
- 2.46
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.49
52W Low $0.55High $2.84
Volume 4.34M
Average 8.14M
Price history
Humacyte, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-58.25%
Period high
$1.49
Period low
$0.35
Latest
$0.50
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 8-K | Sep 28, 2026 | Sep 28, 2026 | |
| 3 | Sep 28, 2026 | Sep 28, 2026 | |
| 3 | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 15, 2026 | Sep 15, 2026 | |
| 25-NSE | Aug 25, 2026 | Aug 25, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13D/A | Aug 18, 2026 | Aug 18, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Jul 31, 2026 | Jul 31, 2026 |
Competitors
Who does Humacyte, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about HUMA's filings, answered from its disclosures.
What is the latest HUMA filing?
The latest filing shown is 8-K dated Nov 10, 2026.
How many recent filings does HUMA have?
Intrinsic Alpha currently shows 20 recent filings for HUMA.
Continue the stock analysis
Jump to another research area for this company.